Therapeutic Neovascularization – Quo vadis?
Springer (Verlag)
978-90-481-7488-1 (ISBN)
Clinical Vascular Growth Factor Therapy for Neovascularization in Patients with Coronary Artery Disease.- The Strengths and Weaknesses of VEGF Adenovirus-Driven Angiogenesis.- Angiogenesis and Arteriogenesis in Diabetes Mellitus: Signal Transduction Defects as the Molecular Basis of Vascular Cell Dysfunction.- Endothelial Activation and Neointimal Hyperplasia: A Double-Edged Sword.- Pampering and Priming the Heart.- Coronary Venous Retroinfusion: A Novel Venue of Regional Induction of Neovascularization.- Integrative Pro-angiogenic Activation: HIF-?.- The Maturation of Vessels – A Limitation to Forced Neovascularization?.- Vascular and Neuronal Development: Intersecting Parallelisms and rossroads.- Cathelicidin Antimicrobial Peptides Modulate Angiogenesis.- The Biology of Embryonic and Adult Endothelial Progenitor Cells.- Signaling Behind Progenitor Cell Mobilization: Focus on Enos and Caveolin.- The Role of Monocytes/Macrophages and Vascular Resident Precursor Cells in Collateral Growth.
Zusatzinfo | X, 262 p. |
---|---|
Verlagsort | Dordrecht |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
Studium ► 1. Studienabschnitt (Vorklinik) ► Physiologie | |
Naturwissenschaften ► Biologie ► Biochemie | |
ISBN-10 | 90-481-7488-0 / 9048174880 |
ISBN-13 | 978-90-481-7488-1 / 9789048174881 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich